- Filed
- Apr 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 23, 2025 | 321.4M sh |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $120M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $119M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.87B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $3.38B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $12.21B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $12.46B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $6.24B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $6.71B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $11.4B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $12.27B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $35.19B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $35.75B |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $408M |
| Capex | Q1 2025 · Mar 31, 2024 | $483M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$114M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.44 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.45 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $421M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $32M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $651M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $7.2B |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $8.3B |